Fonar Corporation (NASDAQ: FONR - Get Free Report) passed above its 200-day moving average during trading on Wednesday. The stock has a 200-day moving average of $16.56 and traded as high as $18.59. Fonar shares last traded at $18.59, with a volume of 81,585 shares trading hands. Wall Street Analysts Forecast Growth Separately, Wall Street

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws

MILWAUKEE, March 3, 2026 /PRNewswire/ -- Ademi LLP continues to investigate FONAR (NASDAQ: FONR) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Timothy Damadian and an acquisition group consisting of certain members of the FONAR's management team and board of directors and third parties. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995.

Fonar (NASDAQ: FONR - Get Free Report) and Semperit Ag Hld (OTCMKTS:SEIGY - Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, valuation, risk, earnings and institutional ownership. Analyst Recommendations This is a summary of

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws

Cash and cash equivalents decreased 6% to $53.0 million at December 31, 2025, as compared to $56.3 million for the fiscal year-ended June 30, 2025. Total Revenues - Net increased by 2% to $25.5 million for the quarter ended December 31, 2025, versus the corresponding quarter one year earlier.

Shares of Fonar Corporation (NASDAQ: FONR - Get Free Report) crossed above its two hundred day moving average during trading on Wednesday. The stock has a two hundred day moving average of $15.84 and traded as high as $18.64. Fonar shares last traded at $18.52, with a volume of 136,266 shares trading hands. Analyst Upgrades

NEW YORK, Feb. 2, 2026 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who hold stock of FONAR Corporation ("FONR" or the "Company") (NASDAQ: FONR). You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into potential breaches of fiduciary duty by the officers and directors of FONAR Corporation.

Stagezero Life Sciences (OTCMKTS:SZLSF - Get Free Report) and Fonar (NASDAQ: FONR - Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, dividends, earnings and risk. Insider and Institutional Ownership 50.6% of Fonar

PHILADELPHIA, Jan. 27, 2026 /PRNewswire/ -- Investor protection firm Kaskela Law LLC is investigating the proposed buyout of FONAR Corp. (NASDAQ: FONR) ("FONAR") to determine whether the proposed buyout price materially undervalues the company's shares and shortchanges the company's investors.  Click here for additional information: https://kaskelalaw.com/case/fonar-corp/   On December 29, 2025, FONAR announced that it had agreed to be acquired at a price of $19.00 per share in cash.